- Home
- ENOV
ENOV
Enovis Corporation
as of 12-05-2025 3:45pm EST
Enovis Corp is a medical technology company that offers medical devices and services across the continuum of patient care, from injury prevention to joint replacement to rehabilitation after surgery, injury, or degenerative disease. Its reportable segments are Prevention & Recovery (P&R) and Reconstructive (Recon). The company generates the maximum revenue from the Prevention & Recovery segment, which includes products that are used to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports-related injuries. The Reconstructive segment provides a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and surgical productivity tools. Geographically, it derives key revenue from the U.S.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 1.7B | IPO Year: | 2008 |
| Target Price: | $51.17 | AVG Volume (30 days): | 815.6K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -24.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $25.46 - $49.38 | Next Earning Date: | 11-06-2025 |
| Revenue: | $2,233,266,000 | Revenue Growth: | 11.57% |
| Revenue Growth (this year): | 9.27% | Revenue Growth (next year): | 4.56% |
AI-Powered ENOV Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Enovis Corporation (ENOV)
Chief Executive Officer
Avg Cost/Share
$30.97
Shares
6,457
Total Value
$199,973.29
Owned After
102,753
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| McDonald Damien | ENOV | Chief Executive Officer | Sep 11, 2025 | Buy | $30.97 | 6,457 | $199,973.29 | 102,753 |
Compare ENOV vs Leading Stocks
See how ENOV stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.